期刊文献+

甲状腺分化癌组织中雌激素受体的表达 被引量:2

Expression of estrogen receptor in differentiated thyroid carcinoma
下载PDF
导出
摘要 目的:探讨甲状腺分化癌(DTC)组织中雌激素受体(ER)表达的临床意义。方法:应用免疫组化SP法 对43例DTC(包括39例乳头状癌,4例滤泡状癌),30例甲状腺良性腺瘤及16例腺瘤旁正常甲状腺组织进行ER 检测。结果:DTC、甲状腺瘤及正常组织中ER的阳性率分别为53.6%(23/43)、26.7%(8/30)及12.5%(2/16), DTC中ER阳性率明显高于腺瘤及正常组织(P<0.05);DTC组织ER阳性率女性高于男性;<45岁者高于≥45岁 者;与肿瘤大小、病灶多少、肿瘤分期及淋巴结转移无关。结论:DTC可能为雌激素依赖性肿瘤。 Aim: To investigate the clinical significance of estrogen receptor(ER) expression in differentiated thyroid carcinoma(DTC) tissue.Methods: A total of 43 cases of DTC(including 39 cases of papillary thyroid carinoma and 4 cases of follicular thyroid carcinoma),30 cases of thyroid adenoma, and 16 cases of normal thyroid tissue around thyroid adenoma were subjected to detect ER by using immunohistochemical SP method. Results: The positive rates of ER in the DTC,the thyroid adenoma,and normal thyroid tissue were 53.6%(23/43), 26.7%(8/30), and 12.5%(2/16),respectively.The positive rate in DTC was significantly higher than those in the thyroid adenoma and the normal thyroid tissue(P<0.05). The positive rates in female with DTC was significantly higher than that in male, and that in those aged less than 45 years was significantly higher than that in those aged more than 45 years. Conclusion: DTC may be a kind of estrogen-dependent tumor.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2005年第2期281-283,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省医学科技创新人才基金资助项目 2004024 河南省杰出青年科学基金资助项目 512002300
关键词 甲状腺分化癌 雌激素受体 乳头状癌 滤泡状癌 differentiated thyroid carcinoma estrogen receptor papillary thyroid carcinoma follicular thyroid carcinoma
  • 相关文献

参考文献9

  • 1崔文,范连杰,王旭,孔灵玲,高继发,曹慧玲,田德明,梁桂华,王学春,张波.人类甲状腺乳头状癌中ret癌基因活化的研究[J].济宁医学院学报,2000,23(1):4-5. 被引量:3
  • 2殷德涛,王庆兆,卢秀波,邱新光.甲状腺乳头状腺癌E-cadherin、CD44v6的表达[J].郑州大学学报(医学版),2002,37(4):407-409. 被引量:5
  • 3白耀.甲状腺疾病学[M].北京:科技文献出版社,2003.349.
  • 4Weber CJ, Marvin M, Krekun S, et al. Effects of tamoxifen and somatostatin analogue on growth of human medullary,follieular, and papillary, thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies. Surgery, 1990,108(6):1 065.
  • 5Di-Domenico M, Castoria G, Bilancio A, et al. Estradiol activation of human colon carcinoma derived Caco-2 cell growth. Cancer Res, 1996,56(19) : 4 516.
  • 6Lieberman BA. The estrogen receptor activity cycle: dependence on multiple protein interactions. Crit Rev Eukaryote Gene Expr, 1997,7( 1 -2) : 43.
  • 7Kodama T, Fujimoto Y, Obara T, et al. Justification of conservative surgical treatment of childhood thyroid cancer: report of eleven cases and analysis of Japanese literature. Jpn J Cancer Res, 1986,77(8) :799.
  • 8Furlanetto TW, Nguyen LQ, Jameson JL. Estrodiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology, 1999, 140(12) :5 705.
  • 9Lazar V, Bidart JM, Caillou B, et al. Expression of the Na^ +/I^- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. Clin Endocrinol Metab,1999,84(9) :3 228.

二级参考文献5

共引文献9

同被引文献34

  • 1程维刚,殷德涛,卢秀波,邱新光,王庆兆.雌激素受体和细胞增殖周期调控蛋白D1在分化型甲状腺癌中的表达及意义[J].中国癌症杂志,2005,15(2):123-125. 被引量:17
  • 2沈美萍,武正炎,侯大卫,刘翠萍.三苯氧胺抑制雌激素受体阴性的甲状腺癌生长[J].南京医科大学学报(自然科学版),2007,27(5):467-471. 被引量:9
  • 3李文君,史京衡,魏霞芳,石莹,滕小洪,柳啸,吴增常.女性 Graves 病患者外周血性激素及相关受体水平的测定[J].铁道医学,1997,25(2):86-87. 被引量:4
  • 4Mizukami Y, Michgishi T, Nonomura A, et al. Estrogen and estrogen receptors in thyoid carcinomas[J]. J Surg Oncol, 1991, 47(3):165-169.
  • 5姚秀敏,瞿春生,吴英杰,等.ER、PR和CyclinD1、bcl-2、c-bB.2癌蛋自在甲状腺疾病中的免疫表型及与预后相关性研究[J].当代医学,2008,35(7):77-78.
  • 6Lisb6a PC, Curty FH, Moreira RM, et al. Effects of estradiol benzoate on 5'-iodothyronine deiodinase activities in female rat anterior pituitary gland, liver and thyroid gland[J]. Braz J Med Biol Res, 1997, 30(12):1479-1484.
  • 7Banu KS, Govindarajulu P, Aruldhas MM. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action[J]. Endocr Pathol, 2001, 12(3):315-327.
  • 8Sobin LH. Histological typing of thyroid tumours[J].Histopathology,1990,(05):513.
  • 9Pelizzo MR,Boschin IM,Toniato A. Natural history,diagnosis,treatment and outcome of papillary thyroid microcarcinoma (PTMC):a mono-institutional 12-year experience[J].Nuclear Medicine Communications,2004,(06):547-552.
  • 10Grodski S,Delbridge L. An update on papillary microcarcinoma[J].Current Opinion in Oncology,2009,(01):1-4.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部